Showing results (1261-1270 of 5,986) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|May 9, 2019
The RNA-Binding Protein HuR Confers Oxaliplatin Resistance of Colorectal Cancer By Upregulating CDC6Jian Cai, Huaiming Wang, Xiaodong Jiao, et al.
Molecular Cancer Therapeutics|September 19, 2018
Targeting Peroxisome Proliferator-Activated Receptor γ to Increase Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer CellsPing Fan, Balkees Abderrahman, Tina S Chai, et al.
Molecular Cancer Therapeutics|September 21, 2018
Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic TypeYemin Wang, Shary Yuting Chen, Shane Colborne, et al.
Molecular Cancer Therapeutics|June 30, 2019
Monomer Preference of EGFR Tyrosine Kinase Inhibitors Influences the Synergistic Efficacy of Combination Therapy with CetuximabAyano Oashi, Hiroyuki Yasuda, Keigo Kobayashi, et al.
Molecular Cancer Therapeutics|October 11, 2019
Synergy between EphA2-ILs-DTXp, a Novel EphA2-Targeted Nanoliposomal Taxane, and PD-1 Inhibitors in Preclinical Tumor ModelsWalid S Kamoun, Anne-Sophie Dugast, James J Suchy, et al.
Molecular Cancer Therapeutics|September 27, 2018
Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic CancersJoel D Maust, Christy L Frankowski-McGregor, Armand Bankhead, et al.
Molecular Cancer Therapeutics|April 4, 2018
Adaptive Resistance to Chemotherapy, A Multi-FAK-torial LinkageKristin N Taylor, David D Schlaepfer
Molecular Cancer Therapeutics|June 29, 2017
Inhibition of Megakaryocyte Differentiation by Antibody-Drug Conjugates (ADCs) is Mediated by Macropinocytosis: Implications for ADC-induced ThrombocytopeniaHui Zhao, Sara Gulesserian, Sathish Kumar Ganesan, et al.
Molecular Cancer Therapeutics|June 30, 2017
A Novel Theranostic Strategy for MMP-14-Expressing Glioblastomas Impacts SurvivalSuchismita Mohanty, Zixin Chen, Kai Li, et al.
Molecular Cancer Therapeutics|July 1, 2017
Inactivation of the Kinase Domain of CDK10 Prevents Tumor Growth in a Preclinical Model of Colorectal Cancer, and Is Accompanied by Downregulation of Bcl-2Louis-Bastien Weiswald, Mohammad R Hasan, John C T Wong, et al.
Pageof 599